Skip to main content
GRCE logo

GRCE · Grace Therapeutics, Inc. · Analyst Estimates

Track GRCE — free
$2.22 -0.04 (-1.77%) At close · Sep 11
Market Cap
$46.70M
Shares
21.04M

Analyst Estimates

Compare analyst forecasts for Grace Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1444192 CUSIP 00439U104 13F (30d) 23 filings 23 filers Visit website Investor relations